|
[1]MUNIRAJ T, CHARI ST.Diabetes and pancreatic cancer[J].Minerva Gastroenterol Edietologica, 2012, 58 (4) :331-345.
|
|
[2]PANNALA R, LEIRNESS JB, BAMLET WR, et al.Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus[J].Gastroenterology, 2008, 134 (4) :981-987.
|
|
[3]AGGARWAL G, KAMADA P, CHARI ST.Prevalence of diabetes mellitus in pancreatic cancer compared to common cancers[J].Pancreas, 2013, 42 (2) :198-201.
|
|
[4]CHAUDHRY ZW, HALL E, KALYANI RR, et al.Diabetes and pancreatic cancer[J].Curr Prob Cancer, 2013, 37 (5) :287-292.
|
|
[5]LI D, TANG H, HASSAN MM, et al.Diabetes and risk of pancreatic cancer:a pooled analysis of three large case-control studies[J].Cancer Causes Control, 2011, 22 (2) :189-197.
|
|
[6]BEN Q, XU M, NING X, et al.Diabetes mellitus and risk of pancreatic cancer:a meta-analysis of cohort studies[J].Eur J Cancer, 2011, 47 (13) :1928-1937.
|
|
[7]LEE MS, HSU CC, WAHLQVIST ML, et al.Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese:a representative population prospective cohort study of 800, 000 individuals[J].BMC Cancer, 2011, 11:20.
|
|
[8]ELENA JW, STEPLOWSKI E, YU K, et al.Diabetes and risk of pancreatic cancer:a pooled analysis from the pancreatic cancer cohort consortium[J].Cancer Causes Control, 2013, 24 (1) :13-25.
|
|
[9]HE XY, LI JF, YAO WY, et al.Resolution of new-onset diabetes after radical pancreatic resection predicts long-term survival in patients with pancreatic ductal cell adenocarcinoma[J].Ann Surg Oncol, 2013, 20 (12) :3809-3816.
|
|
[10]KUANG TT, JIN DA Y, WANG DS, et al.Clinical epidemiological analysis of the relationship between pancreatic cancer and diabetes mellitus:data from a single institution in China[J].J Dig Dis, 2009, 10 (1) :26-29.
|
|
[11]MIZUNO S, NAKAI Y, ISAYAMA H, et al.Diabetes is a useful diagnostic clue to improve the prognosis of pancreatic cancer[J].Pancreatology, 2013, 13 (3) :285-289.
|
|
[12]PANNALA R, BASU A, PETERSEN GM, et al.New-onset diabetes:a potential clue to the early diagnosis of pancreatic cancer[J].Lancet Oncol, 2009, 10 (1) :88-95.
|
|
[13]MIZUNO S, NAKAI Y, ISAYAMA H, et al.Risk factors and early signs of pancreatic cancer in diabetes:screening strategy based on diabetes onset age[J].J Gastroenterol, 2013, 48 (2) :238-246.
|
|
[14]WU JM, KUO TC, YANG CY, et al.Resolution of diabetes after pancreaticoduodenectomy in patients with and without pancreatic ductal cell adenocarcinoma[J].Ann Surg Oncol, 2012, 20 (1) :242-249.
|
|
[15]CANNON RM, LeGRAND R, CHAGPAR RB, et al.Multi-institutional analysis of pancreatic adenocarcinoma demonstrating the effect of diabetes status on survival after resection[J].HPB (Oxford) , 2012, 14 (4) :228-235.
|
|
[16]RAGHAVAN SR, BALLEHANINNA UK, CHAMBERLAIN RS.The impact of perioperative blood glucose levels on pancreatic cancer prognosis and surgical outcomes:an evidence-based review[J].Pancreas, 2013, 42 (8) :1210-1217.
|
|
[17]CHEON YK, KOO JK, LEE YS, et al.Elevated hemoglobin A1c levels are associated with worse survival in advanced pancreatic cancer patients with diabetes[J].Gut Liver, 2014, 8 (2) :205-214.
|
|
[18]TORIOLA AT, STOLZENBERG-SOLOMON R, DALIDOWITZ L, et al.Diabetes and pancreatic cancer survival:a prospective cohort-based study[J].Br J Cancer, 2014.[Epub ahead of print]
|
|
[19]YACHIDA S, JONES S, BOZIC I, et al.Distant metastasis occurs late during the genetic evolution of pancreatic cancer[J].Nature, 2010, 467 (7319) :1114-1117.
|
|
[20]CHIU CC, HUANG CC, CHEN YC, et al.Increased risk of gastrointestinal malignancy in patients with diabetes mellitus and correlations with anti-diabetes drugs:a nationwide population-based study in Taiwan[J].Intern Med, 2013, 52 (9) :939-946.
|
|
[21]WANG Z, LAI ST, XIE L, et al.Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus:a systematic review and meta-analysis[J].Diabetes Res Clin Pract, 2014.[Epub ahead of print].
|
|
[22]TANG H, WEI P, DUELL EJ, et al.Genes-environment interactions in obesity-and diabetes-associated pancreatic cancer:a GWAS data analysis[J].Cancer Epidemiol Biomarkers Prev, 2014, 23 (1) :98-106.
|
|
[23]KISFALVI K, EIBL G, SINNETT-SMITH J, et al.Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth[J].Cancer Res, 2009, 69 (16) :6539-6545.
|
|
[24]LI W, YUAN Y, HUANG L, et al.Metformin alters the expression profiles of microRNAs in human pancreatic cancer cells[J].Diabetes Res Clin Pract, 2012, 96 (2) :187-195.
|
|
[25]LI D, YEUNG SC, HASSAN MM, et al.Antidiabetic therapies affect risk of pancreatic cancer[J].Gastroenterology, 2009, 137 (2) :482-488.
|
|
[26]SINGH S, SINGH PP, SINGH AG, et al.Anti-diabetic medications and risk of pancreatic cancer in patients with diabetes mellitus:a systematic review and meta-analysis[J].Am J Gastroenterol, 2013, 108 (4) :510-519.
|
|
[27]LI D.Diabetes and pancreatic cancer[J].Mol Carcinog, 2012, 51 (1) :64-74.
|
|
[28]ZHOU L, ZHANG R, WANG L, et al.Upregulation of REG Ialpha accelerates tumor progression in pancreatic cancer with diabetes[J].Int J Cancer, 2010, 127 (8) :1795-1803.
|
|
[29]OSMAN MA, SARKAR FH, RODRIGUEZ-BOULAN E.A molecular rheostat at the interface of cancer and diabetes[J].Biochim Biophys Acta, 2013, 1836 (1) :166-176.
|
DownLoad: